T 98475

Drug Profile

T 98475

Latest Information Update: 07 Apr 2003

Price : $50

At a glance

  • Originator Takeda
  • Class Hormones
  • Mechanism of Action Gonadotropin releasing hormone inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 07 Apr 2003 No development reported - Preclinical for Cancer in Japan (PO)
  • 14 Jun 2000 Profile reviewed but no significant changes made
  • 17 Feb 1999 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top